Sveriges mest populära poddar
Optimum Perspectives
Hälsa och motionVetenskap

Verona Pharma: Preparing a potentially novel COPD medicine for market

18 min•24 juli 2023
A much-anticipated new potential drug for COPD moved a step closer to the market after Verona Pharma submitted its New Drug Application to the U.S. FDA, seeking approval of ensifentrine as a maintenance therapy. In its latest podcast, Optimum Strategic Communications caught up with Chris Martin, Senior Vice President of Commercial, who discussed how the company plans to launch this potential novel COPD medicine.

Hosted on Acast. See acast.com/privacy for more information.

Fler avsnitt av Optimum Perspectives

Visa alla avsnitt av Optimum Perspectives
How sleep architecture shapes brain health: new frontiers in Alzheimer’s research
•20 min
Closing the gap on rare diseases in 2026
•19 min
Why who funds science matters
•27 min
Tackling the threat of AMR
•31 min
The ups and downs of ADCs – where to now?
•30 min
Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease
•23 min
Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025
•24 min
Stronger together: changing the future of muscle wasting condition
•30 min
How bioengineered spider silk-based proteins are changing the world
•12 min
How to have a perfect IPO on NASDAQ
•24 min

Optimum Perspectives med Optimum Strategic Communications finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.